Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose
Public ClinicalTrials.gov record NCT00034840. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Randomized, Double-Blind, Forced Titration Trial to Compare the Efficacy of MICARDIS® (Telmisartan 80 mg p.o. Once Daily) and Diovan® (Valsartan 160 mg p.o. Once Daily) Using Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Hypertension After Missing One Dose
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objectives are to demonstrate that MICARDIS® (telmisartan) is statistically superior to Diovan® (valsartan) in reducing diastolic blood pressure (DBP) following a missed dose at the end of a 6 to 8-week treatment period as measured by the 24-hour ABPM mean and to demonstrate that MICARDIS® is statistically superior to Diovan® in reducing DBP during the last 6-hours of the 24-hour dosing interval as measured by ABPM following a dose of active study medication at the end of a 6 to 8-week treatment period.
Study identification
- NCT ID
- NCT00034840
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 490 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2001 (Type not available)
- Primary completion
- Aug 2002 (Actual)
- Completion
- Aug 2002 (Type not available)
- Last update posted
- Nov 1, 2013
2001 – 2002
United States locations
- U.S. sites
- 16
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Memorial Research Medical Clinic | Long Beach | California | 90806 | — |
| National Research Institute | Los Angeles | California | 90057 | — |
| Orange County Research Center | Orange | California | 92868 | — |
| University of Conn. Health Services Center, Hypertension and Vascular Disease | Farmington | Connecticut | 06030 | — |
| Alan Graff | Fort Lauderdale | Florida | 33308 | — |
| Greater Ft. Lauderdale Heart Group Research | Fort Lauderdale | Florida | 33308 | — |
| Orlando Clinical Research Center | Orlando | Florida | 32806 | — |
| So. Clinical Research and Management, Inc. | Augusta | Georgia | 30904 | — |
| Rush Presbyterian/St. Luke's Medical Center | Chicago | Illinois | 60612 | — |
| University of Maryland/Nephrology Clinical Research Unit | Baltimore | Maryland | 21201 | — |
| Washington University | St Louis | Missouri | 63110 | — |
| Oklahoma Cardiovascular and Hypertension Center | Oklahoma City | Oklahoma | 73132 | — |
| Michael A. Azorr, M.D. | Portland | Oregon | 97232 | — |
| Harleysville Medical Associates | Harleysville | Pennsylvania | 19438 | — |
| Trinity Hypertension Research Institute/Punzi Medical Center | Carrollton | Texas | 75006 | — |
| UW Health/Physicians Plus Center for Clinical Trials | Madison | Wisconsin | 53715 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00034840, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 1, 2013 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00034840 live on ClinicalTrials.gov.